General Information of This Antibody
Antibody ID
ANTI0ZWSJH
Antibody Name
hz49E10H1H5L7
Organization
CURON BIOPHARMACEUTICAL (SHANGHAI) CO., LIMITED
Synonyms
hz49E1OH1H5L7
   Click to Show/Hide
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized lgG1-kappa
Antigen Name
Neural cell adhesion molecule L1 (L1CAM)
 Antigen Info 
Click to Show/Hide the Sequence Information of This Antibody
Heavy Chain Sequence
DVQLQESGPGLVKPSQTLSLTCTVSGGSISSDYAWNWIRQPPGKGLEWMGYITYSGTTTY
NPSLKSRITISRDTSKNQFSLKLSSVTAADTAVYYCARDHYGNYAYFDYWGQGTTVTVSS
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSS
GLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGG
PSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVIHNAKTKPREEQY
NSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRE
EMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSR
WQQGNVFSCSVMHEALIHNHYTQKSLSLSPGK
    Click to Show/Hide
Heavy Chain Varible Domain
DVQLQESGPGLVKPSQTLSLTCTVSGGSISSDYAWNWIRQPPGKGLEWMGYITYSGTTTY
NPSLKSRITISRDTSKNQFSLKLSSVTAADTAVYYCARDHYGNYAYFDYWGQGTTVTVSS
    Click to Show/Hide
Heavy Chain CDR 1
GGSISSDYA
    Click to Show/Hide
Heavy Chain CDR 2
ITYSGTT
    Click to Show/Hide
Heavy Chain CDR 3
ARDHYGNYAYFDY
    Click to Show/Hide
Light Chain Sequence
QIQMTQSPSSLSASVGDRVTITCRASSSVSFMHWYQQKPGKAPKPWIYASSNLVSGVPSR
FSGSGSGTDYTLTISSLQPEDFATYYCQQWSSNPSTFGGGTKVEIKRTVAAPSVFIFPPS
DEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTL
SKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
    Click to Show/Hide
Light Chain Varible Domain
QIQMTQSPSSLSASVGDRVTITCRASSSVSFMHWYQQKPGKAPKPWIYASSNLVSGVPSR
FSGSGSGTDYTLTISSLQPEDFATYYCQQWSSNPSTFGGGTKVEIK
    Click to Show/Hide
Light Chain CDR 1
SSVSF
    Click to Show/Hide
Light Chain CDR 2
ASS
    Click to Show/Hide
Light Chain CDR 3
QQWSSNPST
    Click to Show/Hide
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
hz49E10H1H5L7-MMAE [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.092 nM
High L1CAM expression (L1CAM +++)
Method Description
HeLa cells are cultured in DMEM complete medium (Corning, 10-013-CVR) containing 10% FBS (Gibco, 10099-141) and 100 U/mL penicillin-streptomycin mixture (Thermofisher, 15140122). When the cell coverage in the culture container reaches 80-90%, TrypLE (Thermofisher, 12604-013) is used to digest the HeLa cells from the culture container, and they are seeded in a 96-well cell culture plate (Greiner, 655098) at a density of 3.3X103 cells/mL, with 500 cells per well (145uL complete medium),and the 96-well plate is incubated at 37°C overnight. The next day, (ADC) is diluted in complete medium in a 4-fold serial dilution, with 9 concentration gradient points. Then, 5uL of dilution of the ADC molecule is added to each well in the 96-well cell culture plate, gently mixed, and the 96-well plate is incubated at 37°C for 6 days. Finally, 75 uL of CTG is added to each well, gently mixed, and the 96-well plate is incubated at room temperature for 10 minutes. Then the luminescence signal is detected using a multimode microplate reader (PerkinElmer Envision 2105). A dose-inhibition curve is generated, and the half-maximal inhibitory concentration (IC50) is calculated using non-linear regression with GraphPad software.

   Click to Show/Hide
In Vitro Model Endocervical adenocarcinoma HeLa cells CVCL_0030
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
90 nM
Low L1CAM expression (L1CAM+)
Method Description
HeLa L1CAM-KO cells are cultured in DMEM complete medium (Corning, 10-013-CVR) containing 10% FBS (Gibco, 10099-141) and 100 U/mL penicillin-streptomycin mixture (Thermofisher, 15140122). When the cell coverage in the culture container reaches 80-90%, TrypLE (Thermofisher, 12604-013) is used to digest the HeLa L1CAM-KO cells from the culture container, and they are seeded in a 96-well cell culture plate (Greiner, 655098) at a density of 3.3X103 cells/mL, with 500 cells per well (145uL complete medium),and the 96-well plate is incubated at 37°C overnight. The next day, (ADC) is diluted in complete medium in a 4-fold serial dilution, with 9 concentration gradient points. Then, 5uL of dilution of the ADC molecule is added to each well in the 96-well cell culture plate, gently mixed, and the 96-well plate is incubated at 37°C for 6 days. Finally, 75 uL of CTG is added to each well, gently mixed, and the 96-well plate is incubated at room temperature for 10 minutes. Then the luminescence signal is detected using a multimode microplate reader (PerkinElmer Envision 2105). A dose-inhibition curve is generated, and the half-maximal inhibitory concentration (IC50) is calculated using non-linear regression with GraphPad software.

   Click to Show/Hide
In Vitro Model Human papillomavirus-related endocervical adenocarcinoma HeLa cells (L1CAM KO) CVCL_0030
References
Ref 1 Humanized L1CAM antibody-drug conjugate